Abstract: An ear-infrared (NIR) induced decomposable polymer nanocapsule is demonstrated. The nanocapsules are fabricated based on layer-by-layer co-assembly of azobenzene functionalizedp olymers and up/downconversion nanoparticles (U/DCNPs). When the nanocapsules are exposed to 980 nm light, ultraviolet/visible photons emitted by the U/ DCNPs can trigger the photoisomerization of azobenzene groups in the framework. The nanocapsules could decompose from large-sized nanocapsule to small U/DCNPs.O wing to their optimizedo riginal size( ca. 180 nm), the nanocapsules can effectively avoid biological barriers,provide along blood circulation (ca. 5h,half-life time) and achieve four-fold tumor accumulation. It can fast eliminate from tumor within one hour and release the loaded drugs for chemotherapya fter NIRinduced dissociation from initial 180 nm capsules to small 20 nm U/DCNPs.
Nanoparticles have emerged as promising carriers for drugs in cancer treatment owing to the enhanced permeability and retention (EPR) effect, increasing delivery efficiency, and suppressing side effects. [1] [2] [3] Thed esign and development of sophisticated nanocarriers for targeted delivery of theranostic agents to solid tumors hold great promise for improving treatment efficacya nd minimizing systemic toxicity.H owever,n anomedicine often suffers from multiple biological barriers,especially the low accumulation &delivery efficiency toward tumor because of clearance by organs during circulation in the blood stream. [4] It has been demonstrated that the particle size plays av ital role in dominating the delivery efficiency:particles with adiameter of 100-200 nm generally provide long-lasting blood circulation and less clearance of organs. [5] [6] [7] [8] Thus,the conventional solution for size-dependent high accumulation in tumor is to optimize particle diameter to this range.H owever, large nanocarriers are difficult to be eliminated from the organs after their functionalities exhausted. [6, 8] Therefore,i ti sc ritically desired to develop next-generation smart theranostic agents: [9, 10] nanocarriers with al arge initial size (100-200 nm) to cross biological barriers,p rovide prolonged blood circulation and achieve high tumor accumulation, which then could be responsively decomposed into small fragments to release loaded guests and be quickly metabolized.
Much effort has been made to develop stimuli-triggered delivery systems in response to ag iven stimulus,s uch as pH, [11] [12] [13] [14] temperature, [15, 16] and enzyme. [17] Among these approaches,l ight-triggered drug delivery has attracted much attention because it does not rely on changes in specific chemical properties of environment. [18] [19] [20] Av ariety of lightresponsive systems have been designed based on ultraviolet (UV) or visible (Vis) light excitations with low tissue penetration and are biological harmful. [21] As ap romising candidate,near-infrared (NIR) light would bring new opportunities owing to minimal absorbance and maximum penetration of tissues. [22] [23] [24] Thep olymer nanocapsules,i nw hich polymers can act as a"cage" and encapsulate small functional nanoparticles or drugs.However,unlike condensed materials, polymers are more likely to deform and reshape. [25] [26] [27] Thus they are often chosen as building blocks of stimuli responsive systems.
Herein, taking the advantages of the core-shell structured NaGdF 4 ,Yb,Tm@NaYF 4 @NaGdF 4 ,Nd@NaYF 4 dual-mode up/ downconversion nanoparticles (U/DCNPs) [28, 29] and light-responsive polymer,w ed emonstrate an ovel NIR light-responsive decomposable polymer nanocapsule ( Figure 1 ). The1 80 nm nanocapsules were constructed through as imple electrostatic interaction induced layer-bylayer assembly strategy on the surface of spherical SiO 2 colloids (Supporting Information, Figure S1 ). [30, 31] U/DCNPs with negative surface charges [32] [33] [34] were also incorporated in the polymer shells during the alternative assembly of polymers.T he hollow-structured nanocapsules can be obtained after the SiO 2 templates were selectively etched. To realize the NIR-responsive decomposition of the nanocapsules,t he U/DCNPs were doped with Tm 3+ to transmit NIR photons into UV/Vis photons,and UV/Vis sensitive azo functional group was also introduced into the polymer frameworks ( Figure 1 ). [35] Thereversible photo-isomerization of the azo group in the polymer framework stimulated by UV/ Visu pconversion luminescence creates continuous rotationinversion movement, inducing the decomposing of initial 180 nm nanocapsules into scattered polymers and 20 nm U/ DCNPs.T he transportation, accumulation, and metabolization of the nanocarriers can be carefully monitored based on the NIR window (NIR-II) downconversion fluorescence of the core/multishell structured U/DCNPs.O wing to its large initial size (ca. 180 nm), the nanocapsules can provide long blood circulation and enhance accumulation in tumor. The nanocapsules can be controlled to disassemble into small 20 nm U/DCNPs upon NIR light stimulation, releasing the loaded drugs and going through efficient elimination from the tumor site.S uch decomposability renders the nanocapsules with ah igh tumor accumulation as well as NIR stimuli triggered fast elimination.
Thec ore-multishell structured NaGdF 4 :Yb,Tm@NaYF 4 @N aGdF 4 :Nd@NaYF 4 U/DCNPs were fabricated and employed to functionalize the polymer nanocapsules (Supporting Information, Figure S2 ). [36, 37] In this nanostructure,T m 3+ doped nanoparticles were constructed as core for emission of UV/Vis upconversion luminescence under 980 nm excitation. TheN aGdF 4 :Nd layer can emit downconversion NIR-II fluorescence under 800 nm excitation for downconversion bio-imaging.T ransmission electron microscopy (TEM) and the high-angle annular dark-field scanning TEM (HAADF-STEM) images ( Figure 2A )o ft he as-prepared U/DCNPs show discernible contrast for the multi-layer structure with au niform diameter of about 20 nm. Highresolution TEM images ( Figure 2B )and the X-ray diffraction (XRD) patterns (Supporting Information, Figure S3 ) of the obtained U/DCNPs show that the nanoparticles are ah ighly crystalline hexagonal phase without any remarkable impurity.
Tw ot ypes of polymers,p oly(diallyldimethylammonium chloride) (PDADMAC) and poly[1-{4-(3-carboxy-4-hydroxyphenylazo)benzenesulfonamido}-1,2-ethanediyl] (PAZO), with positive and negative charges,r espectively,w ere layerby-layer assembled through electrostatic interaction onto the surface of colloidal SiO 2 nanoparticles.Negatively charged U/ DCNPs were anchored into the composites in the same way. TEM images of the obtained nanocomposites clearly show uniform core-shell structured SiO 2 @polymer@U/DCNP nanocomposites ( Figure 2C ). Uniform hollow nanocapsules with small U/DCNPs embedded in the shells were obtained after etching of the SiO 2 templates (Figure 2D ,E). The polymer shells retained the spherical structure very well, and the size of the nanocapsules shrank from 200 to 180 nm. Thenanocapsules possess NIR-to-UV/Vis upconversion optical properties under 980 nm excitation as well as downconversion NIR-to-NIR-II fluorescence at around 1060 nm excited by 808 nm light ( Figure 2F ). Theresult shows that the intensity of the upconversion luminescent emissions in the UV/blue region (300-500 nm) were significantly lowered after coating of the azo groups containing polymer.M ore than 85 %o ft he photoenergy at about 310 and 365 nm was transferred to the polymer shells owing to the strong absorption in the UV region. About 30 %ofthe photoenergy at circa 475 nm was absorbed by the polymer shells (Figure 2G) . Thed ecomposability of the nanocapsules was carefully examined. TEM images of the nanocapsules after ac ertain period of NIR radiation clearly display the decomposition process:t he nanocapsules are completely intact at the beginning ( Figure 3A) ; an obvious collapse is observed after 1.5 Wcm À2 980 nm irradiation for 15 min (Supporting Information, Figure S4 ). After 30 min, the polymer frameworks are totally dissociated and the embedded small U/ DCNPs are released ( Figure 3B ). With the increase of NIR irradiation duration, the maximal absorbance of the azo moiety at 350 nm decreases considerably,indicating that UV and visible light from U/DCNP inlays can cause the trans-cis photo-isomerization of azo molecules in the polymer frameworks ( Figure 3C ). Dynamic light scattering (DLS) measurements show that the diameter of the nanocapsules shifts from about 180 to about 20 nm after 980 nm irradiation for 30 min, which is consistent with the sizes of the nanocapsules and U/ DCNPs ( Figure 3D ). Ther esults clearly indicate that the isomerization of azo group eventually led to the disassembly of the polymer frameworks,r ealizing the decomposing procedure of the nanocapsules. [38] [39] [40] Thec omposition of the nanocapsules have strong effects on their decomposability.W ithout enough U/DNCPs to convert NIR into UV/Vis ( Supporting Information, Figure S7) , the decomposability of the nanocapsules would be seriously hindered (Supporting Information, Figure S8 ). On the other hand, the thickness of the polymer shells is also very important. When the number of layers of the assembly charged polymers is less than 8, for example 5, the polymers cannot support the U/DCNPs,t hus the hollow structure collapsed after etching of the SiO 2 template (Supporting Information, Figure S9 ). When the number of the polymer layer is more than 8, the stability of the structure is significantly improved. However,i ft he thickness of the polymer shell increases alone without tuning the amount of the embedded U/DCNPs,the structure would be too stable to be decomposed ( Supporting Information, Figure S10) . Thus, the ratio of nanoparticle/polymer should be carefully monitored to achieve satisfying decomposability.T he size of the nanocapsules can also be well tuned by using colloidal SiO 2 nanospheres with different diameters,a nd the decomposing ability can be retained very well (Supporting Information, Figures S11-S13) . By alternately introducing of the polymers and inorganic nanoparticles,the hollow-structured nanocomposites with nanoparticles anchored to multiple layers can be obtained ( Supporting Information, Figure S14 ).
An in vivo bio-distribution study was then conducted. The nanocapsules were very stable in ab road pH range and various biological media ( Supporting Information, Figure S15) , which laid af oundation for the long-term intracorporeal circulation. Nude mice bearing U87-MG solid tumors were intravenously injected at the caudal vein with the U/DCNP-functionalized nanocapsules ( Figure 4A ). Considering the optimal particle size for along blood circulation and high accumulation in tumor,t he initial U/DCNP-functionalized polymer nanocapsules with the diameter of 180 nm were selected. [41, 42] Bio-distribution and tumor accumulation were monitored by Nd 3+ dominated down-conversion NIR-II fluorescence under 800 nm excitation ( Figure 4B ). The results clearly reveal that the NIR-II fluorescence signal at the tumor sites for the 180 nm nanocapsule group is extremely bright in 6h,compared with that of the free U/DCNPs under the same condition (to avoid the interaction from the signal of non-interested area, as creener with only the tumor area exposed was used). TheNIR-II downconversion fluorescence signal can last over 48 h, which is much longer than that of bare U/DCNPs,s uggesting the enhanced accumulation in tumor due to EPR effect with optimized size (Supporting Information, Figure S17 ). However,after applying 1.5 Wcm
À2
980 nm radiation on the tumor region for only 5min at 6h post-injection, the fluorescence signal faded swiftly and totally vanished after merely 6h.S uch quick elimination demonstrates the fast internal clearance owing to the smaller size of the dissociated U/DCNPs.Compared with the free U/ DCNPs,t he large nanocapsules exhibit significantly higher accumulation rate at tumor sites owing to the longer blood retention and higher propensity of extravasation across the vasculature owing to the large size (Figure 4C ,D;Supporting Information, Figure S18 ). There is as ignificant decrease in the concentration of Gd 3+ for the nanocapsules injection group after exposing the tumor to the radiation of 1.5 Wcm À2 980 nm for 5min ( Figure 4C ). It is attributed to the fast clearance of small 20 nm U/DCNPs after the decomposition of the initial large nanocapsules.O nt he basis of the above results,i tc an be concluded that the NIR-responsive decomposable nanocapsules can not only provide prolonged blood circulation, and thus achieve highly efficient accumulation in the tumor,b ut also decomposes into small-sized fragment nanoparticles for fast clearance.
Drugs loaded in the nanocapsules can be released during the decomposing process.DOX could reach a50% release in 60 min ( Figure 5A ;S upporting Information, Figure S19 ) under the irradiation of 1.5 Wcm À2 980 nm light. In sharp contrast, less than 10 %ofDOX was leached out without the NIR irradiation-induced decomposing.A ccording to the cell viability evaluation, DOX-loaded nanocapsules showed asignificantly enhanced cytotoxicity to the cancer cells upon prolonged irradiation time,w hile control groups missing any of the three key elements do not result in any significant decrease in the cell viability ( Figure 5B ). Encouraged by the NIR light-responsive release of drugs,the DOX-loaded smart decomposable nanocapsules were used in the chemotherapy of U87-MG solid tumor. Owing to the high tumor accumulation efficiency and NIR triggered controllable drug release, as ignificantly improved therapeutic effect was observed ( Figures 5C,DSupporting Information, Figure S23 ). These results are consistent with that of the hematoxylin and eosin (H&E) staining analysis ( Figure 5E ;Supporting Information, Figure S24 ). No remarkable tissue damage or any other side effect was observed on heart, liver, spleen, lung, kidney,a nd weight fluctuations,i ndicating ag ood biocompatibility and negligible toxicity of this smart decomposable drug-delivery system. In summary,NIR-responsive decomposable drug delivery nanocapsules with controllable sizes (180-500 nm) were fabricated through layer-by-layer self-assembly of U/DCNPs and light-responsive polymers.9 80 nm NIR light can trigger the decomposition process of the U/DCNP-polymer nanocomposite,t ransforming the particle from large-sized nanocapsules to small-sized polymer fractions and U/DCNP nanoparticles.A ccording to the results of the in vivo downconversion NIR-II monitoring of the circulation, accumulation, and metabolism, the nanocapsules with optimized initial large particle size (180 nm) can effectively avoid biological barriers,p rovide al ong blood circulation (ca. 5h halflifetime) and achieve four-fold tumor accumulation. The NIR-induced dissociation from initial large capsules to small polymer fractions and 20 nm U/DCNPs allows af ast elimination from tumor within an hour and releases the loaded drugs for chemotherapy.T he smart delivery and release capability of this NIR-activated decomposable nanocarriers lays solid foundations towards an ovel platform for nextgeneration nano-therapeutics with both spatial and temporal external control. 
